AgingResearch.NewsJoin free

China National Biotec Group Company

CompanyChina

China National Biotec Group Company develops one asset, in phase 3 (covid-19 vaccine in COVID-19). Mostly vaccine; based in China.

1
Asset
Furthest
Phase 3
7
Trials
0
Signals

Pipeline

1

  • covid-19 vaccine

    Inactivated SARS-CoV-2 induces protective immune responses against COVID-19.

    Phase 3, Vaccine, COVID-19, COVID-19 pneumonia

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials8
  • Similar companies6

Updated 10 Oct 2026 · 18 sources

Intelligence